In the BioHarmony Drug Report Database

"Preview" Icon

Letrozole

Femara (letrozole) is a small molecule pharmaceutical. Letrozole was first approved as Femara on 1997-07-25. It is used to treat breast neoplasms in the USA. The pharmaceutical is active against aromatase.

 

Trade Name

 

Femara
 

Common Name

 

letrozole
 

ChEMBL ID

 

CHEMBL1444
 

Indication

 

breast neoplasms
 

Drug Class

 

Aromatase inhibitors (imidazole/triazole derivatives)

Image (chem structure or protein)

Letrozole structure rendering